- Home
- PLSE vs IHS Comparison
PLSE vs IHS Comparison
Compare PLSE & IHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLSE | IHS |
|---|---|---|
| Founded | 2014 | 2001 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 2.5B |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PLSE | IHS |
|---|---|---|
| Price | $14.19 | $7.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $22.00 | $9.32 |
| AVG Volume (30 Days) | 183.4K | ★ 1.0M |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.37 |
| Revenue | $86,000.00 | ★ $1,765,825,000.00 |
| Revenue This Year | N/A | $3.49 |
| Revenue Next Year | $1,002.94 | $2.77 |
| P/E Ratio | ★ N/A | $5.37 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.56 | $2.90 |
| 52 Week High | $25.00 | $8.00 |
Technical Indicators
Market Signals| Indicator | PLSE | IHS |
|---|---|---|
| Relative Strength Index (RSI) | 49.94 | 58.46 |
| Support Level | $13.12 | $7.45 |
| Resistance Level | $14.75 | $7.96 |
| Average True Range (ATR) | 0.64 | 0.25 |
| MACD | 0.24 | 0.03 |
| Stochastic Oscillator | 70.56 | 51.22 |
Price Performance
Historical ComparisonAbout PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
About IHS IHS Holding Limited
IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria, Sub-Saharan Africa, the Middle East and North Africa (MENA), and Latin America (Latam). The majority of its revenue is derived from Nigeria.